Lead Product(s) : Bisacodyl
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Sanofi
Deal Size : Inapplicable
Deal Type : Inapplicable
MRI Assessment of Mode of Action of Bisacodyl, Single Dose
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 21, 2019
Lead Product(s) : Bisacodyl
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Sanofi
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bisacodyl
Therapeutic Area : Gastroenterology
Study Phase : Phase IV
Sponsor : Sanofi
Deal Size : Inapplicable
Deal Type : Inapplicable
MRI Assessment of Mode of Action of Bisacodyl, Multiple Doses
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
October 17, 2019
Lead Product(s) : Bisacodyl
Therapeutic Area : Gastroenterology
Highest Development Status : Phase IV
Sponsor : Sanofi
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bisacodyl
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 08, 2014
Lead Product(s) : Bisacodyl
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bisacodyl
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 08, 2014
Lead Product(s) : Bisacodyl
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Bisacodyl
Therapeutic Area : Undisclosed
Study Phase : Phase IV
Sponsor : McMaster University
Deal Size : Inapplicable
Deal Type : Inapplicable
Colonoscopy Preparation Optimization for INpatients- COIN Study
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
June 25, 2012
Lead Product(s) : Bisacodyl
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Sponsor : McMaster University
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
